photo free
Home Images Vectors Videos

Stock image COVID-19 experimental antiviral drug MOLNUPIRAVIR,two white pills with letters engraved on side,potential experimental WHO Coronavirus cure,pandemic outbreak crisis,isolated on blue background

Stock image COVID-19 experimental antiviral drug MOLNUPIRAVIR,two white pills with letters engraved on side,potential experimental WHO Coronavirus cure,pandemic outbreak crisis,isolated on blue background
Published: Dec.08, 2020 13:29:26
Author: drecun
Views: 61
Downloads: 10
File type: image / jpg
File size: 12.09 MB
Orginal size: 5616 x 3744 px
Available sizes:
S
(500 x 333)
M
(1000 x 667)
L
(2000 x 1333)
XL
(5616 x 3744)
EL0
(5616 x 3744)
Level: beginner
Download Image
Image topics:

Similar stock images

stock image COVID-19 experimental antiviral drug PAXLOVID,pile of white pills with letters engraved on side,potential experimental WHO Coronavirus cure,pandemic outbreak crisis,isolated on blue background

COVID-19 Experimental Antiviral Drug PAXLOVID,pile Of White Pills With Letters Engraved On Side,potential Experimental WHO Coronavirus Cure,pandemic Outbreak Crisis,isolated On Blue Background

5475 × 3650
stock image Favipiravir experimental drug for treating covid 19 on white background with copy space

Favipiravir Experimental Drug For Treating Covid 19 On White Background With Copy Space

3840 × 5760
stock image Conceptual illustration of experimental antiviral medication drug against Coronavirus COVID-19 disease,global pandemic crisis,therapy & remedy concept,cure & medication to treat SARS-CoV-2 patients

Conceptual Illustration Of Experimental Antiviral Medication Drug Against Coronavirus COVID-19 Disease,global Pandemic Crisis,therapy & Remedy Concept,cure & Medication To Treat SARS-CoV-2 Patients

5475 × 3650
stock image Molnupiravir - first approved oral anti-viral pills against Covid-19

Molnupiravir - First Approved Oral Anti-viral Pills Against Covid-19

4518 × 3014
stock image Composition with two package of Bayer Aspirin

Composition With Two Package Of Bayer Aspirin

7308 × 4712
stock image United States - december, 16, 2021 Pfizers Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk of Hospitalization or Death by 89 in Interim Analysis of Phase 23 EPIC-HR Study

United States - December, 16, 2021 Pfizers Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89 In Interim Analysis Of Phase 23 EPIC-HR Study

4700 × 4200